Results 61 to 70 of about 735,632 (298)

Translophagy—A potential link between autophagy impairment and translational errors

open access: yesFEBS Letters, EarlyView.
Neurodegenerative diseases are characterised by the accumulation of abnormal proteins and protein aggregates, but their origin often remains unknown. We propose that selective autophagy removes damaged protein‐making machinery, preventing errors during protein synthesis.
Mykola V. Korolchuk   +11 more
wiley   +1 more source

Prospecting the protein design landscape

open access: yesFEBS Letters, EarlyView.
This review outlines the current state of various protein design approaches. We discuss the current possibilities enabled by recently released tools, highlight future avenues to pursue in protein design, and underscore the crucial role of key databases and resources for successful protein design workflows.
Jakob R. Riccabona   +4 more
wiley   +1 more source

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression

open access: yesMolecular Oncology, EarlyView.
In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge   +17 more
wiley   +1 more source

Estrada Index and Some Properties of Partially Signed Graphs [PDF]

open access: yesMathematics Interdisciplinary Research
‎A signed graph is a graph with signed edges‎. ‎Recently‎, ‎a special graph consisting of signed and unsigned edges has been introduced and is called a partially signed graph‎.
Shila Razavi, Gholam Fath-Tabar
doaj   +1 more source

Star complements for ±2 in signed graphs

open access: yesSpecial Matrices, 2022
In this article, we investigate connected signed graphs which have a connected star complement for both −2-2 and 2 (i.e. simultaneously for the two eigenvalues), where −2-2 (resp.
Mulas Raffaella, Stanić Zoran
doaj   +1 more source

Signed graphs with integral net Laplacian spectrum

open access: yesAKCE International Journal of Graphs and Combinatorics, 2023
Given a signed graph [Formula: see text], let [Formula: see text] and [Formula: see text] be its standard adjacency matrix and the diagonal matrix of net-degrees, respectively.
M. Anđelić   +3 more
doaj   +1 more source

Differential expression of cancer‐related genes supports prediction of poor response to first‐line treatments in T‐ALL pediatric patients with high minimal residual disease

open access: yesMolecular Oncology, EarlyView.
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera   +11 more
wiley   +1 more source

Bipartite Consensus Problems on Second-Order Signed Networks With Heterogeneous Topologies

open access: yesIEEE Access, 2020
This paper is devoted to the convergence problem for second-order signed networks that are associated with two signed graphs in the presence of heterogeneous topologies.
Jianheng Ling   +2 more
doaj   +1 more source

Balancing signed graphs

open access: yesDiscrete Applied Mathematics, 1981
AbstractA signed graph based on F is an ordinary graph F with each edge marked as positive or negative. Such a graph is called balanced if each of its cycles includes an even number of negative edges. Psychologists are sometimes interested in the smallest number d=d(G) such that a signed graph G may be converted into a balanced graph by changing the ...
Jin Akiyama   +3 more
openaire   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy